NEUROENDOCRINE; CARCINOMA
Clinical trials for NEUROENDOCRINE; CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE; CARCINOMA trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE; CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ZG006 takes on chemo in advanced cancer battle
Disease control Not yet recruitingThis study tests a new drug called ZG006 against standard chemotherapy for people with advanced neuroendocrine carcinoma, a type of cancer. About 240 adults who have already had other treatments will be randomly assigned to receive either ZG006 or a chemotherapy chosen by their d…
Matched conditions: NEUROENDOCRINE; CARCINOMA
Phase: PHASE3 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New radiation drug targets tough cancers in early trial
Disease control Not yet recruitingThis early study tests a new drug (177Lu-DTPA-SC16.56) that delivers radiation directly to cancer cells in people with small-cell lung cancer or neuroendocrine prostate cancer that has come back after standard chemotherapy. The main goal is to find the safest dose and see if the …
Matched conditions: NEUROENDOCRINE; CARCINOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC